Mitomics

Mitomics develops mitochondrial genome-based molecular tests to improve clinical insight and therapeutic decisions that affect patients.

Based, Mitomics works in biotechnology, genetics, health care, life science, founded in 2001.

Mitomics is positioned in biotechnology, genetics, health care, life science, a segment that rewards a clear, focused offering.

Its current recorded stage is Series_Unknown.

Its team size is recorded as c_00011_00050 employees.

Public records show total funding of about $2.9M.

Website: mitomicsinc.com